228 related articles for article (PubMed ID: 15224273)
1. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?
Labbate LA; Sonne SC; Randal CL; Anton RF; Brady KT
Compr Psychiatry; 2004; 45(4):304-10. PubMed ID: 15224273
[TBL] [Abstract][Full Text] [Related]
2. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
4. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.
Brady KT; Sonne SC; Roberts JM
J Clin Psychiatry; 1995 Nov; 56(11):502-5. PubMed ID: 7592501
[TBL] [Abstract][Full Text] [Related]
5. Symptom improvement in co-occurring PTSD and alcohol dependence.
Back SE; Brady KT; Sonne SC; Verduin ML
J Nerv Ment Dis; 2006 Sep; 194(9):690-6. PubMed ID: 16971821
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
[TBL] [Abstract][Full Text] [Related]
7. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
[TBL] [Abstract][Full Text] [Related]
8. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.
Brady KT; Sonne S; Anton RF; Randall CL; Back SE; Simpson K
Alcohol Clin Exp Res; 2005 Mar; 29(3):395-401. PubMed ID: 15770115
[TBL] [Abstract][Full Text] [Related]
9. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
[TBL] [Abstract][Full Text] [Related]
10. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression.
Ramaswamy S; Driscoll D; Reist C; Smith LM; Albers LJ; Rose J; Nguyen L; Monga V; Doria R; Hollifield M
Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28858440
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
[TBL] [Abstract][Full Text] [Related]
12. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
Rapaport MH; Endicott J; Clary CM
J Clin Psychiatry; 2002 Jan; 63(1):59-65. PubMed ID: 11838628
[TBL] [Abstract][Full Text] [Related]
13. Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study.
Sher L; Stanley BH; Posner K; Arendt M; Grunebaum MF; Neria Y; Mann JJ; Oquendo MA
Psychiatry Res; 2012 Apr; 196(2-3):261-6. PubMed ID: 22397913
[TBL] [Abstract][Full Text] [Related]
14. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
Londborg PD; Hegel MT; Goldstein S; Goldstein D; Himmelhoch JM; Maddock R; Patterson WM; Rausch J; Farfel GM
J Clin Psychiatry; 2001 May; 62(5):325-31. PubMed ID: 11411812
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders.
Sannibale C; Teesson M; Creamer M; Sitharthan T; Bryant RA; Sutherland K; Taylor K; Bostock-Matusko D; Visser A; Peek-O'Leary M
Addiction; 2013 Aug; 108(8):1397-1410. PubMed ID: 25328957
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: Assessor-blinded, randomized controlled study.
Feng B; Zhang Y; Luo LY; Wu JY; Yang SJ; Zhang N; Tan QR; Wang HN; Ge N; Ning F; Zheng ZL; Zhu RM; Qian MC; Chen ZY; Zhang ZJ
Psychiatry Clin Neurosci; 2019 Apr; 73(4):179-186. PubMed ID: 30565342
[TBL] [Abstract][Full Text] [Related]
17. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Silverstone PH; Salinas E
J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
[TBL] [Abstract][Full Text] [Related]
19. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.
Escalona R; Canive JM; Calais LA; Davidson JR
Depress Anxiety; 2002; 15(1):29-33. PubMed ID: 11816050
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
